BioVentrix, a company out of San Ramon, California, landed CE Mark approval in the EU for its Revivent TC system that allows for reconstruction of the left ventricule without an open heart surgery. The minimally invasive system can be an option over traditional open-chest surgical ventricular restoration, particularly for fragile patients who would not be good candidates for a more invasive procedure.
Heart attacks can kill significant amount of myocardial tissue within the left ventricle, weakening it, and increasing ventricular wall tension if dilation occurs (via LaPlace’s Law). Reducing the volume of the ventricle can allow it to be more efficient, but post-myocardial infarction patients can have a hard time making through open heart surgery.
The Revivent TC system involves the delivery of pairs of anchors that compress and clamp the left ventricle. This is done through a few ports outside the body via which the tools are delivered to meet up within the heart.
Here’s a company video explaining the Revivent TC procedure:
Product page: Revivent TC…
Via: BioVentrix…
